kidney disease glp 1 GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic GLP-1s and Kidney Disease​: Benefits

The team used medical records to track both groups for a year

Statistical analysis Statistical analyses were conducted via GraphPad Prism 8 (GraphPad Software, San Diego, CA)

However, when we have more options to give patients that they can tolerate better, then it kind of alleviates all of those nightmares of, This is a horrific journey, and, Its not going to work for me. Overall, we have medicines that work with your body to fight the cancer in ways that we just havent had before

Common adverse effects include nausea, constipation, diarrhea, vomiting, dyspepsia, abdominal pain, headache, abdominal distension, fatigue, eructation, GERD, flatulence, and hair loss

However, further studies are needed to fully understand their effects, particularly on EAT and HFpEF [43]